TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.550
-0.060 (-1.30%)
May 6, 2026, 3:16 PM EDT - Market open
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 45.15M | 29.43M | 18.51M | 12.40M | 8.40M | |
| 53.41% | 58.99% | 49.31% | 47.58% | 54.60% | |
| 45.15M | 29.43M | 18.51M | 12.40M | 8.40M | |
| 53.41% | 58.99% | 49.31% | 47.58% | 54.60% | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|
| 45.15M | 29.43M | 18.51M | 12.40M | 8.40M | |
| 53.41% | 58.99% | 49.31% | 47.58% | 54.60% | |
| 45.15M | 29.43M | 18.51M | 12.40M | 8.40M | |
| 53.41% | 58.99% | 49.31% | 47.58% | 54.60% | |
Source: S&P Global Market Intelligence.
